5 patents
Utility
Activatable interleukin-2 polypeptides and methods of use thereof
27 Dec 22
The disclosure features fusion proteins that are conditionally active variants of IL-2.
William Winston, Daniel Hicklin, Vinay Bhaskar, Luke Evnin, Patrick Baeuerle, Jose Andres Salmeron Garcia, Heather Brodkin, Cynthia Seidel-Dugan
Filed: 10 Nov 21
Utility
Activatable interleukin 12 polypeptides and methods of use thereof
27 Sep 22
The disclosure features fusion proteins that are conditionally active variants of IL-12.
William Winston, Daniel Hicklin, Vinay Bhaskar, Luke Evnin, Patrick Baeuerle, Jose Andres Salmeron Garcia, Heather Brodkin, Cynthia Seidel-Dugan
Filed: 21 May 20
Utility
Activatable interleukin-2 polypeptides and methods of use thereof
7 Jun 22
The disclosure features fusion proteins that are conditionally active variants of IL-2.
William Winston, Daniel Hicklin, Vinay Bhaskar, Luke Evnin, Patrick Baeuerle, Jose Andres Salmeron Garcia, Heather Brodkin, Cynthia Seidel-Dugan
Filed: 21 May 20
Utility
Activatable interleukin 12 polypeptides
29 Jun 20
The disclosure features fusion proteins that are conditionally active variants of IL-12.
William Winston, Daniel Hicklin, Vinay Bhaskar, Luke Evnin, Patrick Baeuerle, Jose Andres Salmeron Garcia, Heather Brodkin, Cynthia Seidel-Dugan
Filed: 10 Jun 19
Utility
Activatable interleukin-2 polypeptides
29 Jun 20
The disclosure features fusion proteins that are conditionally active variants of IL-2.
William Winston, Daniel Hicklin, Vinay Bhaskar, Luke Evnin, Patrick Baeuerle, Jose Andres Salmeron Garcia, Heather Brodkin, Cynthia Seidel-Dugan
Filed: 10 Jun 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first